Priority Date: 22.10.13 (US 201361894294P)

MRNA THERAPY FOR ARGININOSUCCINATE SYNTHETASE DEFICIENCY

  • Application ID: EP18205194
  • Status: The application has been published

Attorney

operating since 1848
Headquarter in London and 2 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Carpmaels & Ransford LLP is specialized in A61. Carpmaels & Ransford LLP is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 22.10.2013 - Priority Date (US 201361894294P)
  • 26.06.2019 - Publication A1 (EP3501605)